Rank | Gene Set | Z-score |
---|---|---|
1 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.02055875 |
2 | endocrine pancreas development (GO:0031018) | 6.92325692 |
3 | COPII vesicle coating (GO:0048208) | 6.80414123 |
4 | signal peptide processing (GO:0006465) | 6.58772674 |
5 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.53312919 |
6 | protein maturation by protein folding (GO:0022417) | 6.19667325 |
7 | protein retention in ER lumen (GO:0006621) | 5.97164807 |
8 | peptide hormone processing (GO:0016486) | 5.91157821 |
9 | sequestering of metal ion (GO:0051238) | 5.60873442 |
10 | type B pancreatic cell development (GO:0003323) | 5.60777900 |
11 | glandular epithelial cell differentiation (GO:0002067) | 5.55239725 |
12 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.43925978 |
13 | glandular epithelial cell development (GO:0002068) | 5.23320526 |
14 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.19724336 |
15 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.19181144 |
16 | positive regulation of nuclease activity (GO:0032075) | 5.14601324 |
17 | vesicle coating (GO:0006901) | 4.97798272 |
18 | ER overload response (GO:0006983) | 4.89021934 |
19 | insulin secretion (GO:0030073) | 4.78061274 |
20 | positive regulation of insulin secretion (GO:0032024) | 4.73271768 |
21 | regulation of nuclease activity (GO:0032069) | 4.67999614 |
22 | exocrine pancreas development (GO:0031017) | 4.67354062 |
23 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.63869098 |
24 | cellular response to unfolded protein (GO:0034620) | 4.58668311 |
25 | cellular response to topologically incorrect protein (GO:0035967) | 4.39429499 |
26 | ER-nucleus signaling pathway (GO:0006984) | 4.36375159 |
27 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.15747744 |
28 | regulation of insulin secretion (GO:0050796) | 4.06514141 |
29 | columnar/cuboidal epithelial cell development (GO:0002066) | 4.02923552 |
30 | regulation of glucokinase activity (GO:0033131) | 4.00002222 |
31 | regulation of hexokinase activity (GO:1903299) | 4.00002222 |
32 | positive regulation of peptide hormone secretion (GO:0090277) | 3.95174102 |
33 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.81877263 |
34 | positive regulation of peptide secretion (GO:0002793) | 3.78746331 |
35 | regulation of peptide hormone secretion (GO:0090276) | 3.74718481 |
36 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.72579722 |
37 | response to endoplasmic reticulum stress (GO:0034976) | 3.70342142 |
38 | regulation of peptide secretion (GO:0002791) | 3.66779996 |
39 | toxin metabolic process (GO:0009404) | 3.66642566 |
40 | cellular zinc ion homeostasis (GO:0006882) | 3.64524705 |
41 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.64473123 |
42 | cellular response to vitamin D (GO:0071305) | 3.64427961 |
43 | peptidyl-asparagine modification (GO:0018196) | 3.62089286 |
44 | negative regulation of bone resorption (GO:0045779) | 3.55429606 |
45 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.55097957 |
46 | response to unfolded protein (GO:0006986) | 3.54876854 |
47 | skin morphogenesis (GO:0043589) | 3.50181925 |
48 | detection of calcium ion (GO:0005513) | 3.48537196 |
49 | negative regulation of complement activation (GO:0045916) | 3.48060950 |
50 | protein heterotrimerization (GO:0070208) | 3.46037775 |
51 | peptide hormone secretion (GO:0030072) | 3.44895212 |
52 | response to topologically incorrect protein (GO:0035966) | 3.43060149 |
53 | peptide secretion (GO:0002790) | 3.41156394 |
54 | negative regulation of protein activation cascade (GO:2000258) | 3.39686245 |
55 | keratan sulfate catabolic process (GO:0042340) | 3.36977779 |
56 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.33069413 |
57 | protein N-linked glycosylation (GO:0006487) | 3.31880755 |
58 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.30398751 |
59 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.26409247 |
60 | collagen fibril organization (GO:0030199) | 3.25349437 |
61 | regulation of hormone secretion (GO:0046883) | 3.25005922 |
62 | astrocyte differentiation (GO:0048708) | 3.22649047 |
63 | regulation of complement activation (GO:0030449) | 3.20871121 |
64 | adhesion of symbiont to host cell (GO:0044650) | 3.19056791 |
65 | virion attachment to host cell (GO:0019062) | 3.19056791 |
66 | extracellular matrix assembly (GO:0085029) | 3.16139660 |
67 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.15702993 |
68 | positive regulation of hormone secretion (GO:0046887) | 3.15207709 |
69 | 4-hydroxyproline metabolic process (GO:0019471) | 3.15130213 |
70 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.14493560 |
71 | L-phenylalanine catabolic process (GO:0006559) | 3.14493560 |
72 | epithelial cell fate commitment (GO:0072148) | 3.14223206 |
73 | macroautophagy (GO:0016236) | 3.13696450 |
74 | Golgi organization (GO:0007030) | 3.13602357 |
75 | regulation of protein activation cascade (GO:2000257) | 3.13069551 |
76 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.11751645 |
77 | inner ear receptor cell development (GO:0060119) | 3.11576441 |
78 | positive regulation of glycolytic process (GO:0045821) | 3.11492423 |
79 | negative regulation of fatty acid transport (GO:2000192) | 3.10081125 |
80 | adhesion of symbiont to host (GO:0044406) | 3.09035969 |
81 | surfactant homeostasis (GO:0043129) | 3.07046511 |
82 | nitric oxide mediated signal transduction (GO:0007263) | 3.06432495 |
83 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.05633446 |
84 | negative regulation of insulin secretion (GO:0046676) | 3.05372100 |
85 | positive regulation of extracellular matrix organization (GO:1903055) | 3.04079808 |
86 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.03425397 |
87 | response to hexose (GO:0009746) | 3.02957788 |
88 | regulation of peptide transport (GO:0090087) | 3.02781903 |
89 | cell adhesion mediated by integrin (GO:0033627) | 3.01867346 |
90 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.01144523 |
91 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.01144523 |
92 | lactate metabolic process (GO:0006089) | 3.00540868 |
93 | response to glucose (GO:0009749) | 2.98843724 |
94 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.98675453 |
95 | negative regulation of bone remodeling (GO:0046851) | 2.98550655 |
96 | negative regulation of fibrinolysis (GO:0051918) | 2.97870773 |
97 | glucose homeostasis (GO:0042593) | 2.96548716 |
98 | carbohydrate homeostasis (GO:0033500) | 2.96548716 |
99 | regulation of glucocorticoid secretion (GO:2000849) | 2.96426007 |
100 | protein localization to Golgi apparatus (GO:0034067) | 2.93172407 |
101 | positive regulation of heat generation (GO:0031652) | 2.92869452 |
102 | fibril organization (GO:0097435) | 2.92468600 |
103 | zinc ion homeostasis (GO:0055069) | 2.92063886 |
104 | regulation of fever generation (GO:0031620) | 2.91902996 |
105 | extracellular fibril organization (GO:0043206) | 2.91544441 |
106 | hormone catabolic process (GO:0042447) | 2.90783734 |
107 | response to monosaccharide (GO:0034284) | 2.89861428 |
108 | regulation of apoptotic cell clearance (GO:2000425) | 2.88999592 |
109 | endodermal cell differentiation (GO:0035987) | 2.88935496 |
110 | complement activation, classical pathway (GO:0006958) | 2.88871279 |
111 | intestinal absorption (GO:0050892) | 2.88790720 |
112 | negative regulation of norepinephrine secretion (GO:0010700) | 2.88402834 |
113 | cell migration involved in heart development (GO:0060973) | 2.87472834 |
114 | regulation of plasminogen activation (GO:0010755) | 2.86312392 |
115 | intestinal cholesterol absorption (GO:0030299) | 2.84578195 |
116 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.84361257 |
117 | basement membrane organization (GO:0071711) | 2.82909454 |
118 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.79052462 |
119 | protein targeting to Golgi (GO:0000042) | 2.78163754 |
120 | peptide transport (GO:0015833) | 2.77298244 |
121 | negative regulation of catecholamine secretion (GO:0033604) | 2.76892640 |
122 | induction of positive chemotaxis (GO:0050930) | 2.76865364 |
123 | Golgi vesicle transport (GO:0048193) | 2.76120089 |
124 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.75909982 |
125 | L-phenylalanine metabolic process (GO:0006558) | 2.75909982 |
126 | negative regulation of humoral immune response (GO:0002921) | 2.75021442 |
127 | hormone secretion (GO:0046879) | 2.74297547 |
128 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.74131976 |
129 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.73518813 |
130 | complement activation, alternative pathway (GO:0006957) | 2.70490442 |
131 | collagen metabolic process (GO:0032963) | 2.69932139 |
132 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.68584196 |
133 | gland morphogenesis (GO:0022612) | 2.68033068 |
134 | complement activation (GO:0006956) | 2.64430527 |
135 | regulation of extracellular matrix disassembly (GO:0010715) | 2.60972749 |
136 | cell proliferation involved in metanephros development (GO:0072203) | 2.60640561 |
137 | apoptotic cell clearance (GO:0043277) | 2.59958741 |
138 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.59770709 |
139 | collagen catabolic process (GO:0030574) | 2.55871413 |
140 | low-density lipoprotein particle clearance (GO:0034383) | 2.54982543 |
141 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.54635627 |
142 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.54064733 |
143 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.52849750 |
144 | iron ion import (GO:0097286) | 2.52579160 |
145 | regulation of fibrinolysis (GO:0051917) | 2.51980577 |
146 | positive regulation of cholesterol efflux (GO:0010875) | 2.51903100 |
147 | glomerular basement membrane development (GO:0032836) | 2.50784886 |
148 | extracellular matrix disassembly (GO:0022617) | 2.48998181 |
149 | multicellular organismal metabolic process (GO:0044236) | 2.48925951 |
150 | ovulation from ovarian follicle (GO:0001542) | 2.46661327 |
151 | regulation of cholesterol storage (GO:0010885) | 2.45708511 |
152 | protein carboxylation (GO:0018214) | 2.44874483 |
153 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.44874483 |
154 | chemical homeostasis within a tissue (GO:0048875) | 2.42972510 |
155 | protein activation cascade (GO:0072376) | 2.42881112 |
156 | blood vessel maturation (GO:0001955) | 2.42128534 |
157 | multicellular organismal catabolic process (GO:0044243) | 2.41018300 |
158 | endocardial cushion development (GO:0003197) | 2.39885374 |
159 | positive regulation of cholesterol transport (GO:0032376) | 2.37627743 |
160 | positive regulation of sterol transport (GO:0032373) | 2.37627743 |
161 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.35519798 |
162 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.34322793 |
163 | negative regulation of lipid storage (GO:0010888) | 2.34003498 |
164 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.33383965 |
165 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.30883743 |
166 | type B pancreatic cell proliferation (GO:0044342) | 2.30341623 |
167 | lung vasculature development (GO:0060426) | 2.28974801 |
168 | wound healing, spreading of epidermal cells (GO:0035313) | 2.28296029 |
169 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.26765436 |
170 | tooth mineralization (GO:0034505) | 2.26289140 |
171 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.25176266 |
172 | barbed-end actin filament capping (GO:0051016) | 2.24007540 |
173 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.23207363 |
174 | smooth muscle tissue development (GO:0048745) | 2.23116719 |
175 | response to laminar fluid shear stress (GO:0034616) | 2.22209141 |
176 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.21999175 |
177 | positive regulation of acute inflammatory response (GO:0002675) | 2.20162689 |
178 | metanephric mesenchyme development (GO:0072075) | 2.20048788 |
179 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.19848844 |
180 | regulation of vitamin metabolic process (GO:0030656) | 2.19134797 |
181 | fibrinolysis (GO:0042730) | 2.18995953 |
182 | regulation of macrophage chemotaxis (GO:0010758) | 2.18534039 |
183 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.17091784 |
184 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.16665128 |
185 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.15289978 |
186 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.15214857 |
187 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.14879018 |
188 | regulation of heat generation (GO:0031650) | 2.14447293 |
189 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.14082195 |
190 | detection of molecule of bacterial origin (GO:0032490) | 2.13746773 |
191 | hyaluronan catabolic process (GO:0030214) | 2.13544277 |
192 | regulation of extracellular matrix organization (GO:1903053) | 2.13042780 |
193 | acute-phase response (GO:0006953) | 2.12412100 |
194 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.12271391 |
195 | hypotonic response (GO:0006971) | 2.12162635 |
196 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.12073346 |
197 | positive regulation of blood coagulation (GO:0030194) | 2.11692935 |
198 | positive regulation of hemostasis (GO:1900048) | 2.11692935 |
199 | COPI coating of Golgi vesicle (GO:0048205) | 10.9491642 |
200 | Golgi transport vesicle coating (GO:0048200) | 10.9491642 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.57193478 |
2 | GATA1_22025678_ChIP-Seq_K562_Human | 5.30950067 |
3 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 3.29352995 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.12811431 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.08475349 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.96449817 |
7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.88703632 |
8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84119163 |
9 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.69273221 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.59547390 |
11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.55271763 |
12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.50698689 |
13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.45199197 |
14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.28760038 |
15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.28058518 |
16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.24864263 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20697088 |
18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.18191438 |
19 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.12108296 |
20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.06629034 |
21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.04958142 |
22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.04609029 |
23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.96499632 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91229088 |
25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.88500177 |
26 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.82625506 |
27 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.78013244 |
28 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.77637589 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.74885486 |
30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70987434 |
31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.68999660 |
32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65748301 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.65587280 |
34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.64462826 |
35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59840223 |
36 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.59298053 |
37 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56359581 |
38 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56291782 |
39 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.53763087 |
40 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52091538 |
41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.51959670 |
42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.51155644 |
43 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.49274857 |
44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47985560 |
45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42575351 |
46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40788522 |
47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39122107 |
48 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36832801 |
49 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35399604 |
50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.35174934 |
51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.34548172 |
52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34128019 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31801809 |
54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.31603240 |
55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29776451 |
56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29736880 |
57 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.29687535 |
58 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.29405483 |
59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28829636 |
60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28377472 |
61 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28122277 |
62 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.28095103 |
63 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.27103418 |
64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.26650104 |
65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.26650104 |
66 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26467501 |
67 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25897112 |
68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25811047 |
69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25721880 |
70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25340756 |
71 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24804138 |
72 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24729349 |
73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.24557574 |
74 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24052434 |
75 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.21714068 |
76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20284405 |
77 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.19077227 |
78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.19077227 |
79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16321091 |
80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14955232 |
81 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11541554 |
82 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08660686 |
83 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08659036 |
84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07753258 |
85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07737471 |
86 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06426325 |
87 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06218174 |
88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04139113 |
89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03499776 |
90 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03471336 |
91 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02948144 |
92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02254786 |
93 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.01896131 |
94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00792946 |
95 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00719350 |
96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.00138106 |
97 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.99279458 |
98 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99043688 |
99 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97575799 |
100 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.97428690 |
101 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95892928 |
102 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95801824 |
103 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.95060670 |
104 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.94861432 |
105 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94314035 |
106 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93743860 |
107 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93495635 |
108 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93142092 |
109 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92617058 |
110 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92473240 |
111 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92192235 |
112 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91390671 |
113 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91110534 |
114 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.90857356 |
115 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.89689916 |
116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89529497 |
117 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.89367464 |
118 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89276860 |
119 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.87647797 |
120 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.87372797 |
121 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.87214051 |
122 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86519007 |
123 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85677264 |
124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85495325 |
125 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.85338189 |
126 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85063738 |
127 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84949350 |
128 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.83173073 |
129 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82572227 |
130 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82271792 |
131 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82209289 |
132 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82209289 |
133 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81547687 |
134 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.81179513 |
135 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81062472 |
136 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.80762167 |
137 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80378794 |
138 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.80349250 |
139 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80188471 |
140 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.79910354 |
141 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.79806056 |
142 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.79154288 |
143 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78510098 |
144 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78265421 |
145 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.78011303 |
146 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.76688315 |
147 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.76600340 |
148 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.76037551 |
149 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.75816899 |
150 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.75646337 |
151 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74455513 |
152 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74391487 |
153 | GATA3_26560356_Chip-Seq_TH2_Human | 0.73566571 |
154 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.72831935 |
155 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.71056571 |
156 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.70149720 |
157 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.70147282 |
158 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.70053153 |
159 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.69616817 |
160 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.69236527 |
161 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69142435 |
162 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.68646259 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002877_abnormal_melanocyte_morpholog | 6.01193469 |
2 | MP0003195_calcinosis | 4.16766233 |
3 | MP0002693_abnormal_pancreas_physiology | 4.08628679 |
4 | MP0000013_abnormal_adipose_tissue | 3.88853865 |
5 | MP0009780_abnormal_chondrocyte_physiolo | 3.82993614 |
6 | MP0001944_abnormal_pancreas_morphology | 3.81196269 |
7 | MP0004043_abnormal_pH_regulation | 3.77918328 |
8 | MP0003283_abnormal_digestive_organ | 3.66234420 |
9 | MP0002909_abnormal_adrenal_gland | 3.56322057 |
10 | MP0001958_emphysema | 3.46666458 |
11 | MP0000678_abnormal_parathyroid_gland | 3.22222752 |
12 | MP0005379_endocrine/exocrine_gland_phen | 3.19540352 |
13 | MP0010386_abnormal_urinary_bladder | 3.18430467 |
14 | MP0003183_abnormal_peptide_metabolism | 3.12182722 |
15 | MP0003279_aneurysm | 3.05975600 |
16 | MP0003705_abnormal_hypodermis_morpholog | 2.91047508 |
17 | MP0004272_abnormal_basement_membrane | 2.89539493 |
18 | MP0005220_abnormal_exocrine_pancreas | 2.84911396 |
19 | MP0005365_abnormal_bile_salt | 2.49268470 |
20 | MP0002837_dystrophic_cardiac_calcinosis | 2.47586804 |
21 | MP0002078_abnormal_glucose_homeostasis | 2.39897542 |
22 | MP0008004_abnormal_stomach_pH | 2.37061935 |
23 | MP0003252_abnormal_bile_duct | 2.35819488 |
24 | MP0009840_abnormal_foam_cell | 2.32939773 |
25 | MP0002139_abnormal_hepatobiliary_system | 2.32151879 |
26 | MP0000003_abnormal_adipose_tissue | 2.15940000 |
27 | MP0004264_abnormal_extraembryonic_tissu | 2.08688161 |
28 | MP0003191_abnormal_cellular_cholesterol | 2.05140062 |
29 | MP0006054_spinal_hemorrhage | 1.90335012 |
30 | MP0005023_abnormal_wound_healing | 1.90157643 |
31 | MP0003300_gastrointestinal_ulcer | 1.88841123 |
32 | MP0001542_abnormal_bone_strength | 1.88786315 |
33 | MP0003566_abnormal_cell_adhesion | 1.86001634 |
34 | MP0009384_cardiac_valve_regurgitation | 1.85949378 |
35 | MP0002896_abnormal_bone_mineralization | 1.81061766 |
36 | MP0001986_abnormal_taste_sensitivity | 1.79821974 |
37 | MP0005085_abnormal_gallbladder_physiolo | 1.72390832 |
38 | MP0002138_abnormal_hepatobiliary_system | 1.71424728 |
39 | MP0003868_abnormal_feces_composition | 1.71314761 |
40 | MP0005164_abnormal_response_to | 1.69550226 |
41 | MP0002928_abnormal_bile_duct | 1.67915540 |
42 | MP0006072_abnormal_retinal_apoptosis | 1.67195397 |
43 | MP0003303_peritoneal_inflammation | 1.65523941 |
44 | MP0002638_abnormal_pupillary_reflex | 1.64950012 |
45 | MP0005257_abnormal_intraocular_pressure | 1.61790901 |
46 | * MP0001533_abnormal_skeleton_physiology | 1.61028752 |
47 | MP0000767_abnormal_smooth_muscle | 1.56408443 |
48 | MP0003091_abnormal_cell_migration | 1.56121070 |
49 | MP0000613_abnormal_salivary_gland | 1.54784986 |
50 | MP0005646_abnormal_pituitary_gland | 1.51665743 |
51 | MP0001765_abnormal_ion_homeostasis | 1.44797285 |
52 | MP0010352_gastrointestinal_tract_polyps | 1.44757228 |
53 | * MP0002998_abnormal_bone_remodeling | 1.43743402 |
54 | MP0002254_reproductive_system_inflammat | 1.42942515 |
55 | * MP0002060_abnormal_skin_morphology | 1.42615030 |
56 | MP0002876_abnormal_thyroid_physiology | 1.42384345 |
57 | MP0005645_abnormal_hypothalamus_physiol | 1.41778164 |
58 | MP0003953_abnormal_hormone_level | 1.40722279 |
59 | MP0003172_abnormal_lysosome_physiology | 1.39803577 |
60 | MP0002933_joint_inflammation | 1.39516256 |
61 | MP0009643_abnormal_urine_homeostasis | 1.38314334 |
62 | * MP0003436_decreased_susceptibility_to | 1.34598528 |
63 | * MP0005390_skeleton_phenotype | 1.29356944 |
64 | MP0002108_abnormal_muscle_morphology | 1.27390572 |
65 | MP0003950_abnormal_plasma_membrane | 1.26914885 |
66 | MP0003959_abnormal_lean_body | 1.21591393 |
67 | MP0001756_abnormal_urination | 1.21446651 |
68 | MP0000685_abnormal_immune_system | 1.20447113 |
69 | MP0003828_pulmonary_edema | 1.20074107 |
70 | MP0001666_abnormal_nutrient_absorption | 1.19233550 |
71 | MP0003122_maternal_imprinting | 1.19190874 |
72 | MP0002234_abnormal_pharynx_morphology | 1.19075507 |
73 | MP0008961_abnormal_basal_metabolism | 1.14376261 |
74 | MP0005595_abnormal_vascular_smooth | 1.10910023 |
75 | MP0000343_altered_response_to | 1.09178909 |
76 | MP0006082_CNS_inflammation | 1.08909851 |
77 | MP0004858_abnormal_nervous_system | 1.08781359 |
78 | MP0005636_abnormal_mineral_homeostasis | 1.08343343 |
79 | MP0005058_abnormal_lysosome_morphology | 1.05263365 |
80 | MP0000462_abnormal_digestive_system | 1.03043666 |
81 | MP0003045_fibrosis | 1.01453721 |
82 | MP0001243_abnormal_dermal_layer | 1.01318489 |
83 | MP0009785_altered_susceptibility_to | 1.01057929 |
84 | MP0001879_abnormal_lymphatic_vessel | 1.00623181 |
85 | MP0002118_abnormal_lipid_homeostasis | 1.00433340 |
86 | * MP0004947_skin_inflammation | 0.99021711 |
87 | MP0001270_distended_abdomen | 0.98723897 |
88 | MP0000604_amyloidosis | 0.98292629 |
89 | MP0005375_adipose_tissue_phenotype | 0.97614137 |
90 | MP0000751_myopathy | 0.96585629 |
91 | MP0005387_immune_system_phenotype | 0.95062739 |
92 | MP0001790_abnormal_immune_system | 0.95062739 |
93 | MP0000249_abnormal_blood_vessel | 0.94519280 |
94 | MP0005388_respiratory_system_phenotype | 0.94389971 |
95 | MP0002133_abnormal_respiratory_system | 0.94389971 |
96 | MP0000681_abnormal_thyroid_gland | 0.94271856 |
97 | MP0005165_increased_susceptibility_to | 0.93859814 |
98 | MP0003075_altered_response_to | 0.93673571 |
99 | MP0004510_myositis | 0.92858860 |
100 | MP0004883_abnormal_blood_vessel | 0.91973845 |
101 | MP0005310_abnormal_salivary_gland | 0.88526841 |
102 | MP0000609_abnormal_liver_physiology | 0.88367825 |
103 | MP0008438_abnormal_cutaneous_collagen | 0.88099993 |
104 | MP0003448_altered_tumor_morphology | 0.87767941 |
105 | MP0003941_abnormal_skin_development | 0.87691489 |
106 | MP0001851_eye_inflammation | 0.86925569 |
107 | * MP0002419_abnormal_innate_immunity | 0.85851134 |
108 | MP0005448_abnormal_energy_balance | 0.85739162 |
109 | MP0001661_extended_life_span | 0.83820322 |
110 | MP0005076_abnormal_cell_differentiation | 0.83617553 |
111 | MP0000538_abnormal_urinary_bladder | 0.83299338 |
112 | MP0009764_decreased_sensitivity_to | 0.82622802 |
113 | * MP0002148_abnormal_hypersensitivity_rea | 0.81488949 |
114 | MP0005334_abnormal_fat_pad | 0.81423990 |
115 | MP0000230_abnormal_systemic_arterial | 0.81010405 |
116 | MP0002971_abnormal_brown_adipose | 0.79881192 |
117 | MP0003453_abnormal_keratinocyte_physiol | 0.78884693 |
118 | MP0009115_abnormal_fat_cell | 0.78295456 |
119 | MP0002163_abnormal_gland_morphology | 0.77669185 |
120 | MP0005408_hypopigmentation | 0.77662880 |
121 | MP0002168_other_aberrant_phenotype | 0.77169903 |
122 | MP0003795_abnormal_bone_structure | 0.76453503 |
123 | * MP0002405_respiratory_system_inflammati | 0.75651736 |
124 | MP0010329_abnormal_lipoprotein_level | 0.75289783 |
125 | MP0002115_abnormal_skeleton_extremities | 0.74978513 |
126 | MP0005084_abnormal_gallbladder_morpholo | 0.74720661 |
127 | MP0000639_abnormal_adrenal_gland | 0.73433128 |
128 | MP0000858_altered_metastatic_potential | 0.72859018 |
129 | * MP0005535_abnormal_body_temperature | 0.72857248 |
130 | MP0010155_abnormal_intestine_physiology | 0.72590090 |
131 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71799768 |
132 | MP0003890_abnormal_embryonic-extraembry | 0.71463267 |
133 | * MP0009642_abnormal_blood_homeostasis | 0.70010904 |
134 | MP0001502_abnormal_circadian_rhythm | 0.69647338 |
135 | MP0002128_abnormal_blood_circulation | 0.68408330 |
136 | MP0000631_abnormal_neuroendocrine_gland | 0.68391406 |
137 | MP0003119_abnormal_digestive_system | 0.67858342 |
138 | MP0001614_abnormal_blood_vessel | 0.66517302 |
139 | MP0000163_abnormal_cartilage_morphology | 0.65494485 |
140 | MP0001175_abnormal_lung_morphology | 0.65346918 |
141 | MP0005166_decreased_susceptibility_to | 0.65039243 |
142 | * MP0005025_abnormal_response_to | 0.65026284 |
143 | MP0005167_abnormal_blood-brain_barrier | 0.65006974 |
144 | MP0002113_abnormal_skeleton_development | 0.64762678 |
145 | MP0005275_abnormal_skin_tensile | 0.64545593 |
146 | MP0002295_abnormal_pulmonary_circulatio | 0.64378482 |
147 | MP0005503_abnormal_tendon_morphology | 0.64364915 |
148 | MP0004782_abnormal_surfactant_physiolog | 0.64363126 |
149 | MP0005670_abnormal_white_adipose | 0.64137525 |
150 | MP0000465_gastrointestinal_hemorrhage | 0.62777887 |
151 | MP0009672_abnormal_birth_weight | 0.62271132 |
152 | MP0001835_abnormal_antigen_presentation | 0.61949140 |
153 | MP0005248_abnormal_Harderian_gland | 0.61734281 |
154 | * MP0005000_abnormal_immune_tolerance | 0.61215832 |
155 | MP0002177_abnormal_outer_ear | 0.61131824 |
156 | MP0001764_abnormal_homeostasis | 0.59795617 |
157 | MP0001299_abnormal_eye_distance/ | 0.59097038 |
158 | MP0000579_abnormal_nail_morphology | 0.58796210 |
159 | MP0005332_abnormal_amino_acid | 0.58088113 |
160 | MP0006292_abnormal_olfactory_placode | 0.57028442 |
161 | MP0010368_abnormal_lymphatic_system | 0.54560605 |
162 | MP0003866_abnormal_defecation | 0.53994678 |
163 | MP0003806_abnormal_nucleotide_metabolis | 0.52397288 |
164 | MP0005508_abnormal_skeleton_morphology | 0.52381636 |
165 | MP0005452_abnormal_adipose_tissue | 0.51159280 |
166 | MP0002009_preneoplasia | 0.50680776 |
167 | MP0003724_increased_susceptibility_to | 0.50424678 |
168 | MP0002970_abnormal_white_adipose | 0.49642892 |
169 | MP0005319_abnormal_enzyme/_coenzyme | 0.47395912 |
170 | MP0005360_urolithiasis | 0.47123676 |
171 | MP0005083_abnormal_biliary_tract | 0.46861625 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 8.01558947 |
2 | Hypoglycemic seizures (HP:0002173) | 7.34743699 |
3 | Symptomatic seizures (HP:0011145) | 6.78422850 |
4 | Hypoglycemic coma (HP:0001325) | 6.74426554 |
5 | Protrusio acetabuli (HP:0003179) | 6.28322924 |
6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.07513568 |
7 | Hyperglycemia (HP:0003074) | 5.91054375 |
8 | Premature rupture of membranes (HP:0001788) | 5.82883096 |
9 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.28729540 |
10 | Aortic dissection (HP:0002647) | 5.05118444 |
11 | Aortic aneurysm (HP:0004942) | 4.86612586 |
12 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.75626431 |
13 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.64548169 |
14 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.64548169 |
15 | Ketoacidosis (HP:0001993) | 4.41975251 |
16 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.36301599 |
17 | Conjugated hyperbilirubinemia (HP:0002908) | 4.18498943 |
18 | Abnormality of the intrinsic pathway (HP:0010989) | 4.09469938 |
19 | Vascular tortuosity (HP:0004948) | 4.07974015 |
20 | Complement deficiency (HP:0004431) | 4.02164964 |
21 | Large for gestational age (HP:0001520) | 3.92443194 |
22 | Late onset (HP:0003584) | 3.85812669 |
23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.81238623 |
24 | Systemic lupus erythematosus (HP:0002725) | 3.75976554 |
25 | Abnormality of complement system (HP:0005339) | 3.71096809 |
26 | Generalized aminoaciduria (HP:0002909) | 3.63780981 |
27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.63301999 |
28 | Mucopolysacchariduria (HP:0008155) | 3.63301999 |
29 | Follicular hyperkeratosis (HP:0007502) | 3.62421742 |
30 | Decreased circulating renin level (HP:0003351) | 3.56855303 |
31 | Soft skin (HP:0000977) | 3.55489125 |
32 | Peritonitis (HP:0002586) | 3.50805525 |
33 | Arterial tortuosity (HP:0005116) | 3.47242913 |
34 | Abnormal pancreas size (HP:0012094) | 3.42796605 |
35 | Osteomalacia (HP:0002749) | 3.34594078 |
36 | Persistence of primary teeth (HP:0006335) | 3.34240758 |
37 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.33398025 |
38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.33398025 |
39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.33398025 |
40 | Ankle contracture (HP:0006466) | 3.23337363 |
41 | Spondylolisthesis (HP:0003302) | 3.20691726 |
42 | Dilatation of the ascending aorta (HP:0005111) | 3.19840673 |
43 | Insulin resistance (HP:0000855) | 3.19529316 |
44 | Abnormality of the common coagulation pathway (HP:0010990) | 3.18535633 |
45 | Bladder diverticulum (HP:0000015) | 3.07236343 |
46 | Dysostosis multiplex (HP:0000943) | 3.06456511 |
47 | Wormian bones (HP:0002645) | 3.06351690 |
48 | Hypokalemia (HP:0002900) | 3.05443999 |
49 | Vertebral compression fractures (HP:0002953) | 2.99318773 |
50 | Cerebral aneurysm (HP:0004944) | 2.98793899 |
51 | Blue sclerae (HP:0000592) | 2.95881211 |
52 | Retinal atrophy (HP:0001105) | 2.92152391 |
53 | Intrahepatic cholestasis (HP:0001406) | 2.90697759 |
54 | Broad metatarsal (HP:0001783) | 2.88842490 |
55 | Atrophic scars (HP:0001075) | 2.88161998 |
56 | Type 1 muscle fiber predominance (HP:0003803) | 2.84302310 |
57 | Agitation (HP:0000713) | 2.83811225 |
58 | Ketosis (HP:0001946) | 2.82311992 |
59 | Glomerulonephritis (HP:0000099) | 2.76738398 |
60 | Deep venous thrombosis (HP:0002625) | 2.76499722 |
61 | Ovoid vertebral bodies (HP:0003300) | 2.75701625 |
62 | Mitral valve prolapse (HP:0001634) | 2.75647754 |
63 | Asymmetric septal hypertrophy (HP:0001670) | 2.72748711 |
64 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.72437255 |
65 | Osteolytic defects of the hand bones (HP:0009699) | 2.72437255 |
66 | Prominent metopic ridge (HP:0005487) | 2.70662965 |
67 | Fragile skin (HP:0001030) | 2.69872997 |
68 | Neonatal short-limb short stature (HP:0008921) | 2.69780055 |
69 | Hypoplasia of the fovea (HP:0007750) | 2.68669322 |
70 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.68669322 |
71 | Aneurysm (HP:0002617) | 2.64936384 |
72 | Unilateral renal agenesis (HP:0000122) | 2.63670694 |
73 | Joint stiffness (HP:0001387) | 2.59927958 |
74 | Abnormality of potassium homeostasis (HP:0011042) | 2.54835992 |
75 | Abnormality of the fovea (HP:0000493) | 2.52129219 |
76 | Thoracolumbar scoliosis (HP:0002944) | 2.50027194 |
77 | Hyperparathyroidism (HP:0000843) | 2.49790964 |
78 | Skin nodule (HP:0200036) | 2.48058088 |
79 | Hyperkalemia (HP:0002153) | 2.47351309 |
80 | Striae distensae (HP:0001065) | 2.43972064 |
81 | Abnormality of the acetabulum (HP:0003170) | 2.38947390 |
82 | Spinal rigidity (HP:0003306) | 2.38309266 |
83 | Joint laxity (HP:0001388) | 2.38130002 |
84 | Flared iliac wings (HP:0002869) | 2.37042725 |
85 | Aortic regurgitation (HP:0001659) | 2.36292866 |
86 | Shallow orbits (HP:0000586) | 2.36188384 |
87 | Thin bony cortex (HP:0002753) | 2.35409970 |
88 | Hyperextensible skin (HP:0000974) | 2.33165099 |
89 | Nephritis (HP:0000123) | 2.31899143 |
90 | Overgrowth (HP:0001548) | 2.31835133 |
91 | Genu recurvatum (HP:0002816) | 2.31163132 |
92 | Interstitial pulmonary disease (HP:0006530) | 2.30330007 |
93 | Abnormality of the metopic suture (HP:0005556) | 2.30186849 |
94 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.29609389 |
95 | Slender build (HP:0001533) | 2.28381742 |
96 | Limb hypertonia (HP:0002509) | 2.24550396 |
97 | Abnormality of dentin (HP:0010299) | 2.23524202 |
98 | Abdominal distention (HP:0003270) | 2.21699859 |
99 | Abnormality of renin-angiotensin system (HP:0000847) | 2.21228902 |
100 | Cardiovascular calcification (HP:0011915) | 2.20353872 |
101 | Hypothermia (HP:0002045) | 2.20069515 |
102 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19714978 |
103 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19714978 |
104 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19714978 |
105 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.18040753 |
106 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.18040753 |
107 | Abnormal protein glycosylation (HP:0012346) | 2.18040753 |
108 | Abnormal glycosylation (HP:0012345) | 2.18040753 |
109 | Abnormal delivery (HP:0001787) | 2.15973872 |
110 | Dysautonomia (HP:0002459) | 2.15483770 |
111 | Prolonged partial thromboplastin time (HP:0003645) | 2.14159407 |
112 | Hypophosphatemia (HP:0002148) | 2.13978350 |
113 | Protuberant abdomen (HP:0001538) | 2.13835680 |
114 | Glucose intolerance (HP:0000833) | 2.12061177 |
115 | Hypsarrhythmia (HP:0002521) | 2.11760930 |
116 | EEG with generalized epileptiform discharges (HP:0011198) | 2.11738939 |
117 | Increased variability in muscle fiber diameter (HP:0003557) | 2.08602791 |
118 | Premature loss of primary teeth (HP:0006323) | 2.08210610 |
119 | Myocardial infarction (HP:0001658) | 2.08135598 |
120 | Hyperphosphatemia (HP:0002905) | 2.06396759 |
121 | Increased connective tissue (HP:0009025) | 2.04601164 |
122 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.03476145 |
123 | Biconcave vertebral bodies (HP:0004586) | 2.03040509 |
124 | Abnormal biliary tract morphology (HP:0012440) | 2.02186536 |
125 | Aortic valve stenosis (HP:0001650) | 2.00791283 |
126 | Exocrine pancreatic insufficiency (HP:0001738) | 2.00588773 |
127 | Congenital glaucoma (HP:0001087) | 2.00574016 |
128 | Hyperactive renin-angiotensin system (HP:0000841) | 1.99858389 |
129 | Epileptiform EEG discharges (HP:0011182) | 1.99336267 |
130 | Macroorchidism (HP:0000053) | 1.92064093 |
131 | Elevated alkaline phosphatase (HP:0003155) | 1.90156632 |
132 | Abnormality of skull ossification (HP:0002703) | 1.89864643 |
133 | Osteoarthritis (HP:0002758) | 1.89821502 |
134 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.87823209 |
135 | Coxa vara (HP:0002812) | 1.84850467 |
136 | Wide anterior fontanel (HP:0000260) | 1.84442007 |
137 | Cystic liver disease (HP:0006706) | 1.82872013 |
138 | Mitral regurgitation (HP:0001653) | 1.82248852 |
139 | Periodontitis (HP:0000704) | 1.80799688 |
140 | Vacuolated lymphocytes (HP:0001922) | 1.80430454 |
141 | Emphysema (HP:0002097) | 1.80241663 |
142 | Abnormality of purine metabolism (HP:0004352) | 1.79038805 |
143 | Cortical visual impairment (HP:0100704) | 1.78548116 |
144 | Cervical subluxation (HP:0003308) | 1.78049672 |
145 | Acne (HP:0001061) | 1.77527349 |
146 | Pulmonary artery stenosis (HP:0004415) | 1.76626745 |
147 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75764023 |
148 | Orchitis (HP:0100796) | 1.74967258 |
149 | Camptodactyly of toe (HP:0001836) | 1.74774612 |
150 | Abnormal glucose tolerance (HP:0001952) | 1.74664043 |
151 | Disproportionate short-trunk short stature (HP:0003521) | 1.74374428 |
152 | Natal tooth (HP:0000695) | 1.74074985 |
153 | Abnormality of carpal bone ossification (HP:0006257) | 1.74015599 |
154 | Intestinal atresia (HP:0011100) | 1.73886309 |
155 | Absent frontal sinuses (HP:0002688) | 1.72971753 |
156 | Femoral bowing (HP:0002980) | 1.72377756 |
157 | Abnormality of the peritoneum (HP:0002585) | 1.72326231 |
158 | Chronic bronchitis (HP:0004469) | 1.72271440 |
159 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.72059964 |
160 | Abnormality of primary teeth (HP:0006481) | 1.71943394 |
161 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.71528569 |
162 | Ectopia lentis (HP:0001083) | 1.70695596 |
163 | Type I transferrin isoform profile (HP:0003642) | 1.70691741 |
164 | Fat malabsorption (HP:0002630) | 1.69411999 |
165 | Long toe (HP:0010511) | 1.69124968 |
166 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.68897164 |
167 | Gastrointestinal infarctions (HP:0005244) | 1.68223834 |
168 | Inguinal hernia (HP:0000023) | 1.68179907 |
169 | Progressive neurologic deterioration (HP:0002344) | 1.68050299 |
170 | Papilledema (HP:0001085) | 1.67443690 |
171 | Elbow flexion contracture (HP:0002987) | 1.66532754 |
172 | Restlessness (HP:0000711) | 1.65502152 |
173 | Enlarged kidneys (HP:0000105) | 1.65431942 |
174 | Thin skin (HP:0000963) | 1.65261944 |
175 | Irregular vertebral endplates (HP:0003301) | 1.65151371 |
176 | Loss of speech (HP:0002371) | 1.64823899 |
177 | Death in childhood (HP:0003819) | 1.64661640 |
178 | Abnormality of chloride homeostasis (HP:0011422) | 1.64006072 |
179 | Hyperbilirubinemia (HP:0002904) | 1.63998015 |
180 | Hypercortisolism (HP:0001578) | 1.62179350 |
181 | Gout (HP:0001997) | 1.61327966 |
182 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.61318361 |
183 | Severe short stature (HP:0003510) | 1.61038766 |
184 | Hypoplasia of the thymus (HP:0000778) | 1.60656768 |
185 | Oligomenorrhea (HP:0000876) | 1.58911752 |
186 | Renal cortical cysts (HP:0000803) | 1.56957529 |
187 | Mitral stenosis (HP:0001718) | 1.55280613 |
188 | Congenital sensorineural hearing impairment (HP:0008527) | 1.54128256 |
Rank | Gene Set | Z-score |
---|---|---|
1 | INSRR | 6.80138429 |
2 | TAOK3 | 4.51586485 |
3 | PASK | 4.33833963 |
4 | PRKD3 | 3.65917786 |
5 | MAPK15 | 3.58494891 |
6 | DDR2 | 3.24849498 |
7 | FRK | 3.16655128 |
8 | HIPK2 | 2.90294637 |
9 | TGFBR2 | 2.88300337 |
10 | IRAK3 | 2.76507928 |
11 | MYLK | 2.73562360 |
12 | ERN1 | 2.51207782 |
13 | MAP3K2 | 2.46512565 |
14 | EPHA3 | 2.25202781 |
15 | FLT3 | 2.22125642 |
16 | WNK3 | 2.03549830 |
17 | LATS2 | 1.79897806 |
18 | KIT | 1.71008091 |
19 | WNK4 | 1.66631783 |
20 | CAMKK2 | 1.64669083 |
21 | TYK2 | 1.63689239 |
22 | AKT3 | 1.53958470 |
23 | MAP3K1 | 1.53877331 |
24 | PDGFRA | 1.51695272 |
25 | PRPF4B | 1.45963463 |
26 | IRAK1 | 1.44458469 |
27 | SCYL2 | 1.44396782 |
28 | TTN | 1.38605496 |
29 | MAP3K13 | 1.36763151 |
30 | GRK7 | 1.30062289 |
31 | BRSK2 | 1.29700592 |
32 | TBK1 | 1.27599918 |
33 | PTK6 | 1.26908021 |
34 | MAP3K6 | 1.23736068 |
35 | PIK3CG | 1.22793382 |
36 | BMPR2 | 1.22770808 |
37 | * CDC42BPA | 1.21433800 |
38 | PRKCH | 1.19260934 |
39 | MAPK7 | 1.15673969 |
40 | PRKD2 | 1.14880430 |
41 | PAK2 | 1.13518130 |
42 | NLK | 1.09087600 |
43 | NTRK3 | 1.08074348 |
44 | TRPM7 | 1.07470890 |
45 | UHMK1 | 1.07238021 |
46 | FGFR4 | 1.05068690 |
47 | PTK2 | 1.01998021 |
48 | ERBB3 | 1.01721595 |
49 | SIK1 | 1.01640503 |
50 | STK38 | 1.00624943 |
51 | BCKDK | 0.98566043 |
52 | MAP3K7 | 0.98546395 |
53 | NTRK1 | 0.97491745 |
54 | ABL2 | 0.96008587 |
55 | TRIB3 | 0.95158992 |
56 | BRD4 | 0.94743274 |
57 | TAOK2 | 0.93736238 |
58 | MOS | 0.93500126 |
59 | JAK1 | 0.91481022 |
60 | MATK | 0.91017345 |
61 | IKBKE | 0.89972137 |
62 | LATS1 | 0.89545036 |
63 | FER | 0.88519960 |
64 | FGFR3 | 0.86147211 |
65 | IRAK2 | 0.85587543 |
66 | BMPR1B | 0.85000949 |
67 | PAK3 | 0.84217289 |
68 | MAP2K3 | 0.77976986 |
69 | MET | 0.77005153 |
70 | JAK2 | 0.76119481 |
71 | RET | 0.75586819 |
72 | JAK3 | 0.73196389 |
73 | DYRK1B | 0.73050356 |
74 | PDPK1 | 0.72534072 |
75 | BLK | 0.72492145 |
76 | MAP3K3 | 0.72490452 |
77 | IRAK4 | 0.71692547 |
78 | PRKAA1 | 0.71214994 |
79 | ADRBK1 | 0.70299528 |
80 | EIF2AK3 | 0.70222178 |
81 | CSK | 0.68277684 |
82 | EPHB2 | 0.68052797 |
83 | GRK6 | 0.67172372 |
84 | STK38L | 0.66638952 |
85 | PRKCE | 0.66317433 |
86 | DMPK | 0.64498937 |
87 | WNK1 | 0.62980579 |
88 | ADRBK2 | 0.62467969 |
89 | IKBKB | 0.60429749 |
90 | RPS6KB1 | 0.59661627 |
91 | NUAK1 | 0.59451774 |
92 | MARK2 | 0.58597610 |
93 | MAP2K1 | 0.58472791 |
94 | STK3 | 0.58356158 |
95 | ICK | 0.56865689 |
96 | GSK3A | 0.55038808 |
97 | CLK1 | 0.53290513 |
98 | MAP2K2 | 0.52974254 |
99 | TESK1 | 0.52890448 |
100 | SGK2 | 0.51269824 |
101 | CHUK | 0.51048774 |
102 | ERBB4 | 0.51019301 |
103 | PKN2 | 0.50373904 |
104 | TEC | 0.49883143 |
105 | EPHB1 | 0.49098976 |
106 | ITK | 0.48848339 |
107 | GRK5 | 0.48630624 |
108 | MTOR | 0.47882906 |
109 | CDK12 | 0.47544075 |
110 | MST1R | 0.47466528 |
111 | NEK6 | 0.47266443 |
112 | PRKAA2 | 0.46635127 |
113 | PDK2 | 0.46622181 |
114 | CAMK2D | 0.45913620 |
115 | MAPKAPK3 | 0.45869739 |
116 | PIM2 | 0.45853889 |
117 | PRKD1 | 0.45826286 |
118 | EPHA2 | 0.45601456 |
119 | PAK4 | 0.44800657 |
120 | IGF1R | 0.44743852 |
121 | RPS6KA2 | 0.43132320 |
122 | RIPK1 | 0.42963401 |
123 | ZAP70 | 0.42628718 |
124 | ZAK | 0.42603795 |
125 | GRK1 | 0.41710668 |
126 | PDGFRB | 0.40727056 |
127 | MAPK12 | 0.40464375 |
128 | PRKACG | 0.38047560 |
129 | RPS6KA4 | 0.36944904 |
130 | MAP3K14 | 0.33391951 |
131 | CSNK1A1 | 0.32382856 |
132 | SGK3 | 0.32218483 |
133 | PRKCI | 0.30199320 |
134 | MELK | 0.28964230 |
135 | CAMKK1 | 0.27231445 |
136 | NEK9 | 0.27229421 |
137 | PIK3CA | 0.25092866 |
138 | AKT1 | 0.25037877 |
139 | SGK223 | 0.23950345 |
140 | SGK494 | 0.23950345 |
141 | BRAF | 0.23419059 |
142 | PRKDC | 0.21927168 |
143 | PRKG2 | 0.21809817 |
144 | MAPK14 | 0.21614708 |
145 | BRSK1 | 0.20044203 |
146 | PRKACA | 0.19438676 |
147 | MAPK3 | 0.19183441 |
148 | CDK9 | 0.18627631 |
149 | SGK1 | 0.18303434 |
150 | TIE1 | 0.18027717 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.28869516 |
2 | Protein export_Homo sapiens_hsa03060 | 5.70889853 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.73556544 |
4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.33939553 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.91196941 |
6 | Insulin secretion_Homo sapiens_hsa04911 | 2.90809319 |
7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.26663012 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23455019 |
9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.21167946 |
10 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.10332658 |
11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.93167053 |
12 | Pertussis_Homo sapiens_hsa05133 | 1.91771198 |
13 | Malaria_Homo sapiens_hsa05144 | 1.90815727 |
14 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.67712844 |
15 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.61421284 |
16 | * Amoebiasis_Homo sapiens_hsa05146 | 1.57873402 |
17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.57546806 |
18 | Focal adhesion_Homo sapiens_hsa04510 | 1.53503651 |
19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.49432551 |
20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46406665 |
21 | ABC transporters_Homo sapiens_hsa02010 | 1.44151240 |
22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.38849440 |
23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35416938 |
24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30401654 |
25 | Lysosome_Homo sapiens_hsa04142 | 1.29884703 |
26 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26414431 |
27 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.23162526 |
28 | Insulin resistance_Homo sapiens_hsa04931 | 1.22860496 |
29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21895268 |
30 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.18067437 |
31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17006116 |
32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16689489 |
33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15697406 |
34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.15000946 |
35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14057319 |
36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10785713 |
37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10523416 |
38 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.10346095 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08710154 |
40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07800384 |
41 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07228195 |
42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.03796500 |
43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03051568 |
44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.02292660 |
45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.02113015 |
46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00969173 |
47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.00330545 |
48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.99298074 |
49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99277189 |
50 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95091256 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93519651 |
52 | Mineral absorption_Homo sapiens_hsa04978 | 0.91208467 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 0.91132994 |
54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.89080367 |
55 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88075012 |
56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.85006728 |
57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84196509 |
58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83910659 |
59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83448439 |
60 | Prion diseases_Homo sapiens_hsa05020 | 0.82391310 |
61 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81649940 |
62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.79202250 |
63 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77606116 |
64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76679662 |
65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76530777 |
66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74803838 |
67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74673197 |
68 | Tuberculosis_Homo sapiens_hsa05152 | 0.74619511 |
69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72746011 |
70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72504886 |
71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.72144316 |
72 | Influenza A_Homo sapiens_hsa05164 | 0.71472181 |
73 | Adherens junction_Homo sapiens_hsa04520 | 0.71413152 |
74 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70626501 |
75 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69108904 |
76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68326648 |
77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67034052 |
78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.66204219 |
79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66150333 |
80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65818874 |
81 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62852632 |
82 | Taste transduction_Homo sapiens_hsa04742 | 0.62531701 |
83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62314946 |
84 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61587540 |
85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61559201 |
86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61341710 |
87 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60734733 |
88 | Lysine degradation_Homo sapiens_hsa00310 | 0.60405829 |
89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58963325 |
90 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57308412 |
91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55814720 |
92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54425295 |
93 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54099956 |
94 | Peroxisome_Homo sapiens_hsa04146 | 0.53846070 |
95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53341612 |
96 | Platelet activation_Homo sapiens_hsa04611 | 0.52947856 |
97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.52507343 |
98 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52347246 |
99 | Measles_Homo sapiens_hsa05162 | 0.52330661 |
100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50252220 |
101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50077118 |
102 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49256018 |
103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49099198 |
104 | Salmonella infection_Homo sapiens_hsa05132 | 0.48864230 |
105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48611729 |
106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48498845 |
107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48270754 |
108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47705552 |
109 | Prostate cancer_Homo sapiens_hsa05215 | 0.47276461 |
110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46963072 |
111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45269183 |
112 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44919670 |
113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44629610 |
114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43958402 |
115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.43066069 |
116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41995866 |
117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41964663 |
118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41870157 |
119 | Hepatitis B_Homo sapiens_hsa05161 | 0.41853850 |
120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41853075 |
121 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41785156 |
122 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39877973 |
123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39818534 |
124 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.38430677 |
125 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37169087 |
126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34660981 |
127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.33792937 |
128 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33256340 |
129 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.32826443 |
130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32040517 |
131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31834245 |
132 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30101733 |
133 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29987303 |
134 | Legionellosis_Homo sapiens_hsa05134 | 0.29824109 |
135 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29725902 |
136 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28791311 |
137 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.27224474 |
138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26638637 |
139 | Bile secretion_Homo sapiens_hsa04976 | 0.25157504 |
140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22469474 |
141 | Bladder cancer_Homo sapiens_hsa05219 | 0.22299224 |
142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21631903 |
143 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19831682 |
144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18823452 |
145 | GABAergic synapse_Homo sapiens_hsa04727 | 0.17584462 |
146 | Long-term potentiation_Homo sapiens_hsa04720 | 0.16497617 |
147 | Renin secretion_Homo sapiens_hsa04924 | 0.16017346 |
148 | Circadian entrainment_Homo sapiens_hsa04713 | 0.16002698 |
149 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.15852784 |
150 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.14220475 |
151 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.13745485 |
152 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.13427571 |
153 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13199956 |
154 | Phagosome_Homo sapiens_hsa04145 | 0.12001433 |
155 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.11880856 |
156 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.10510755 |
157 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.09725897 |